Trade Summary

4 days ago, EVNIN LUKE, serving as Dir at Werewolf Therapeutics, Inc. (HOWL), sold 139,803 shares at $0.46 per share, for a total transaction value of $63,628.06. Following this transaction, EVNIN LUKE now holds 482,776 shares of HOWL.

This sale represents a 22.46% decrease in EVNIN LUKE's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 6:42 PM ET, 2 days after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.